IVEN, a leading player in the pharmaceutical industry, has announced its participation in Pharmaconex 2024, one of the most significant pharmaceutical exhibitions in the Middle East and Africa region. The event is scheduled to take place from September 8-10, 2024, at the Egypt International Exhibition Centre in Cairo.

Pharmaconex 2024, organized in association with CPHI, brings together key stakeholders from across the pharmaceutical value chain. IVEN’s presence at this prestigious event underscores its commitment to expanding its footprint in the rapidly growing Egyptian and African markets.

Visitors to the exhibition will have the opportunity to explore IVEN’s latest offerings and innovations at Booth No. H4. D32A. The company is expected to showcase its cutting-edge technologies and solutions tailored for the pharmaceutical sector.

“We are excited to participate in Pharmaconex 2024 and engage with industry professionals, potential partners, and customers,” Belle said a spokesperson for IVEN. “This exhibition provides an excellent platform to demonstrate our expertise and discuss how our solutions can address the evolving needs of the pharmaceutical industry in the region.”

The three-day event is anticipated to attract thousands of attendees from around the world, offering networking opportunities and insights into the latest trends and advancements in the pharmaceutical field.

IVEN’s participation in Pharmaconex 2024 aligns with its strategic goals to strengthen its presence in emerging markets and foster collaborations within the global pharmaceutical community. The company looks forward to welcoming visitors to its booth and exploring potential partnerships during this significant industry gathering in Cairo.

For more information about IVEN’s participation in Pharmaconex 2024, interested parties are encouraged to visit the company’s booth during the exhibition.